FDA approves generic of AstraZeneca asthma drug (AP via Yahoo! News)
AstraZeneca PLC said Wednesday it is launching a generic version of its own child asthma medication Pulmicort Respules after U.S. regulators paved the way for its rival Teva Pharmaceutical Industries Ltd. to do the same.
Home > About This Post
This entry was posted by admin on Wednesday, November 19th, 2008, at 12:43 pm, and was filed in asthma.
Subscribe to the
RSS 2.0 feed for all comments to this post.
Post a Comment